ARKEMA NOT AS SPECIALTY AS ONE WOULD HOPE (ADD, 18% UPSIDE)
05/05/26 -" Arkema (Add, France) has been a challenging equity story since our last teaser 19 months ago. Our earlier bullish stance was based on expansion into high-growth segments and accretive acquisitions. ..."
Pages
70
Language
English
Published on
05/05/26
You may also be interested by these reports :
28/05/26
H2 2025/26 remained a mixed bag for JMAT, with weak demand and metal losses weighing on Clean Air and PGM Services. EBIT remained dependent on cost ...
27/05/26
Akzo Nobel rejected a €13bn bid from Nippon Paint and Sherwin-Williams, despite the offer implying a 39% premium to its share price. Positive ...
20/05/26
2026/2027: EPS increase is driven by a strong Q1 2026 underpinning management expectations of €1.0bn in 2026 EBITDA. We remain optimistic on earnings ...
20/05/26
We have rebuilt our model after the change in analyst covering the stock and have also updated the model with most recent FY 25 figures. SGL Carbon ...